Blue Owl Capital Holdings’s AEON Biopharma AEON Stock Holding History

Blue Owl Capital Holdings’s Portfolio AEON Stock Details AEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$41.5K	Sell	42,353 -1,042	-2%	-$1.17K	0.01%	57
2025 Q4	$47.7K	Buy	43,395 +1,042	+2%	+$973	0.01%	57
2025 Q3	$34.2K	Hold	42,353	–	–	0.01%	52
2025 Q2	$32.2K	Hold	42,353	–	–	0.01%	53
2025 Q1	$24.6K	Buy	42,353 +1	+0%	+$7	0.01%	52
2024 Q4	$1.65M	Sell	42,352 -4,054	-9%	-$236K	0.38%	32
2024 Q3	$3.51M	Buy	+46,406	New	+$4.08M	0.68%	31

Other funds holding AEON

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FAM

Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Blue Owl Capital Holdings's AEON Position: Q1 2026 in Review

Blue Owl Capital Holdings reduced its AEON Biopharma (AEON) stake by 2.4% in Q1 2026, selling an estimated $1.17K and leaving 42,353 shares worth $41.5K. The position accounts for 0.01% of the portfolio, ranked #57.

Blue Owl Capital Holdings first reported a position in AEON in Q3 2024 and has held it in 7 quarters since. The position peaked at $3.51M in Q3 2024. 24 funds tracked by Wall St. Rank hold AEON as of Q1 2026.

Blue Owl Capital Holdings held 42,353 shares of AEON Biopharma worth $41.5K as of Q1 2026.
Blue Owl Capital Holdings sold 1,042 AEON Biopharma shares in Q1 2026, an estimated $1.17K.
AEON Biopharma made up 0.01% of Blue Owl Capital Holdings's portfolio in Q1 2026, its #57 holding.
Blue Owl Capital Holdings first reported a position in AEON Biopharma in Q3 2024 and has held it in 7 quarters since.
Blue Owl Capital Holdings's AEON Biopharma position peaked at $3.51M in Q3 2024.
24 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2026.

Based on Blue Owl Capital Holdings's 13F filing for Q1 2026, filed 14 May 2026.